The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.EBI
University of California Davis
Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.EBI
University of California Davis
Synthesis and Evaluation of Quinazolines as Inhibitors of the Bacterial Cell Division Protein FtsZ.EBI
University of California Davis
Organosilicon molecules with medicinal applications.EBI
University of California Davis
Orally bioavailable potent soluble epoxide hydrolase inhibitors.EBI
University of California Davis
Novel flavonoids with antiproliferative activities against breast cancer cells.EBI
University of California Davis
Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.EBI
University of California Davis
Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.EBI
University of California Davis
Development of potent inhibitors of the human microsomal epoxide hydrolase.EBI
University of California Davis
-Benzyl-linoleamide, a Constituent of EBI
University of California Davis
Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.EBI
University of California Davis
Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.EBI
University of California Davis
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.EBI
University of California Davis
Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ΔF508 cystic fibrosis transmembrane conductance regulator protein.EBI
University of California Davis
Fluorinated ΔF508-CFTR correctors and potentiators for PET imaging.EBI
University of California Davis
Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.EBI
University of California Davis
Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.EBI
University of California Davis
Adamantyl thioureas as soluble epoxide hydrolase inhibitors.EBI
University of California Davis
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain.EBI
University of California Davis
Indole substituted pyrrolopyrimidinyl inhibitors of Uba6BDB
Millennium Pharmaceuticals
Fused heterocyclic compounds as CaM kinase inhibitorsBDB
Gilead Sciences